IX Biopharma Ltd
SGX:42C
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IX Biopharma Ltd
SGX:42C
|
SG |
|
A
|
Akebia Therapeutics Inc
F:AX9
|
US |
|
O
|
Orkla ASA
DUS:OKL
|
NO |
|
I
|
Inca One Gold Corp
OTC:INCAF
|
CA |
|
Great Elm Capital Corp
F:O4R
|
US |
|
Omer Decugis & Cie SA
PAR:ALODC
|
FR |
|
K
|
KCE Electronics PCL
SET:KCE
|
TH |
|
Maxlinear Inc
F:JMX
|
US |
|
S
|
SAG Holdings Ltd
NASDAQ:SAG
|
SG |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 42C's stock price target?
Not Available
42C does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for IX Biopharma Ltd?
Projected CAGR
50%
The compound annual growth rate for Revenue over the next 1 year is 50%.